xmt-1660
·Code: XMT-1660
xmt-1660: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mersana Therapeutics, Inc. (MRSN) | Phase 1 |
Clinical Trials (1)
A Phase 1, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants With Solid Tumors
Frequently asked questions
Who is developing xmt-1660?
xmt-1660 is being developed by Mersana Therapeutics, Inc..
How many clinical trials involve xmt-1660?
BioSniper tracks 1 clinical trial involving xmt-1660.
Get deeper analysis on xmt-1660
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis